NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis-Reference-Cited by-同舟云学术

NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis

Published:2021-12 Issue: Volume:194 Page:114822
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Zhong Haoxuan,Waresi Maieryemu,Zhang Wei^ORCID,Han Liping,Zhao Yikai,Chen Yufei,Zhou Peng,Chang Lin,Pan Guanxing,Wu Bangwei,Li Jian,Zhang Si,Shi Haiming,Luo Xinping,Gao Wen^ORCID,Qi Zhiyong,Ding Zhongren

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference51 articles.

1. Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors;Joseph;Circ. Res.,2017

2. Mechanisms of acute coronary syndromes and their implications for therapy;Libby;N. Engl. J. Med.,2013

3. Acute myocardial infarction;Reed;Lancet,2017

4. Clinical evidence for oral antiplatelet therapy in acute coronary syndromes;Wiviott;Lancet,2015

5. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor;Thrombosis Research;2024-06

2. Role and molecular mechanism of NOD2 in chronic non-communicable diseases;Journal of Molecular Medicine;2024-05-14

3. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance;Clinical Epigenetics;2023-12-15

4. Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease;BMC Veterinary Research;2023-12-13

5. The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury;Scientific Reports;2023-10-26